Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Wolfson who wrote (60)	10/8/1996 11:55:00 AM
From: Sean Janzen	of 1501

Here's the latest news from IZP. Attention Business Editors: INFLAZYME COMMENCES TRADING ON OTC BULLETIN BOARD VANCOUVER, Oct. 8 /CNW/ - Inflazyme Pharmaceuticals Ltd. (OTC BB: IZYPF, VSE: IZP) announced today that it has received approval to trade its common stock on the OTC Bulletin Board, under the symbol IZYPF. The company's stock will continue to trade on the Vancouver Stock Exchange under its IZP symbol. Inflazyme's President and CEO Dr. Hassan Salari stated, ``We anticipate that the OTC Bulletin Board listing will expand shareholder interest in Inflazyme, and that it will facilitate trading among our following of U.S. investors, which has been increasing steadily.'' Inflazyme is a bio-pharmaceutical company focused on the discovery and development of therapeutic agents for diseases with a major inflammatory component. Inflazyme's lead compound, Apanol, appears to possess unique properties that may make it an orally effective agent for the treatment of asthma. Other lead indications for Inflazyme's developing technologies include allergy and arthritis.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next